The structural profiles are close, with Elanco Animal Health carrying a narrow edge on growth. Viatris still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels.
Most of the separation is still concentrated in growth.
Both operate in: Drug Manufacturers - Specialty & Generic
This comparison is based on industry proximity, not on functional trajectory similarity. ELAN and VTRS share the same industry classification.
For a similarity-based comparison, see how Elanco Animal Health and Viatris each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
The structural gap is limited here, but current pricing still leans against Elanco Animal Health Incorporated.
Valuation position uses Forward P/E where available.
The current lead is backed by a stronger multi-year growth trajectory.
Stability still leans toward Viatris Inc., so the lead is real without reading as one-way.
The main read on growth is clearer than the broader score gap.
Break down the ELAN vs VTRS comparison across all dimensions with the full interactive tool.
Explore how ELAN and VTRS each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.